Viewing Study NCT06440967


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2025-12-25 @ 10:39 PM
Study NCT ID: NCT06440967
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-05-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 2693-CL-1303
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators